Kim HH - Search Results

1

Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.

Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH. Kim HJ, et al. Among authors: kim hh, kim hm, kim hd. Free Radic Biol Med. 2006 May 1;40(9):1483-93. doi: 10.1016/j.freeradbiomed.2005.10.066. Epub 2005 Dec 9. Free Radic Biol Med. 2006. PMID: 16632109

2

A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6.

Shin JN, Kim I, Lee JS, Koh GY, Lee ZH, Kim HH. Shin JN, et al. Among authors: kim hh, kim i. J Biol Chem. 2002 Mar 8;277(10):8346-53. doi: 10.1074/jbc.M110964200. Epub 2001 Dec 20. J Biol Chem. 2002. PMID: 11751921 Free article.

3

Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function.

Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH. Ha H, et al. Among authors: kim hh. J Biol Chem. 2003 May 16;278(20):18573-80. doi: 10.1074/jbc.M212626200. Epub 2003 Mar 11. J Biol Chem. 2003. PMID: 12637570 Free article.

4

Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.

Kim HH, Chung WJ, Lee SW, Chung PJ, You JW, Kwon HJ, Tanaka S, Lee ZH. Kim HH, et al. Exp Cell Res. 2003 Oct 1;289(2):368-77. doi: 10.1016/s0014-4827(03)00288-x. Exp Cell Res. 2003. PMID: 14499638

5

RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.

Kim HH, Shin HS, Kwak HJ, Ahn KY, Kim JH, Lee HJ, Lee MS, Lee ZH, Koh GY. Kim HH, et al. Among authors: kim jh. FASEB J. 2003 Nov;17(14):2163-5. doi: 10.1096/fj.03-0215fje. Epub 2003 Sep 18. FASEB J. 2003. PMID: 14500543

6

Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH.

Kwak HB, Lee SW, Li YJ, Kim YA, Han SY, Jhon GJ, Kim HH, Lee ZH. Kwak HB, et al. Among authors: kim hh, kim ya. Biochem Pharmacol. 2004 Apr 1;67(7):1239-48. doi: 10.1016/j.bcp.2003.10.032. Biochem Pharmacol. 2004. PMID: 15013839

7

Elucidation of CPX-1 involvement in RANKL-induced osteoclastogenesis by a proteomics approach.

Chang EJ, Kwak HB, Kim H, Park JC, Lee ZH, Kim HH. Chang EJ, et al. Among authors: kim hh, kim h. FEBS Lett. 2004 Apr 23;564(1-2):166-70. doi: 10.1016/S0014-5793(04)00338-2. FEBS Lett. 2004. PMID: 15094061 Free article.

8

Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.

Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH. Lee SK, et al. Among authors: kim kk, kim hh, kim hm, kim kh. Exp Cell Res. 2004 Aug 15;298(2):359-68. doi: 10.1016/j.yexcr.2004.04.039. Exp Cell Res. 2004. PMID: 15265685

9

Reactive oxygen species mediate RANK signaling in osteoclasts.

Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH. Ha H, et al. Among authors: kim hh, kim hm. Exp Cell Res. 2004 Dec 10;301(2):119-27. doi: 10.1016/j.yexcr.2004.07.035. Exp Cell Res. 2004. PMID: 15530848

10

Low proliferation and high apoptosis of osteoblastic cells on hydrophobic surface are associated with defective Ras signaling.

Chang EJ, Kim HH, Huh JE, Kim IA, Seung Ko J, Chung CP, Kim HM. Chang EJ, et al. Among authors: kim hh, kim hm, kim ia. Exp Cell Res. 2005 Feb 1;303(1):197-206. doi: 10.1016/j.yexcr.2004.09.024. Exp Cell Res. 2005. PMID: 15572039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,488 results

Search Page